News and Updates from the American Society of Clinical Oncology Annual Meeting
For the physicians treating men with non-metastatic castration resistant prostate cancer, knowing the risk of progression or death provides valuable information to guide the timing and selection of treatment.
Physicians and patients want to do everything possible to minimize the risk of breast cancer recurrence without incurring unnecessary toxicity from chemotherapy.
While guidelines for multiple myeloma advise pharmacologic prophylaxis to prevent development of venous thromboembolism (VTE) in high-risk patients, current risk assessment tools differ in the factors considered indicative of high risk and in the patients determined to need preventive anticoagulation.
Multiple organizations have recommended timely treatment for patients with lung cancer.
The treatment armamentarium for renal cell carcinoma and other genitourinary cancers continues to expand.
More than 95,000 Americans develop colon cancer, making it the third most common cancer in the U.S., excluding skin cancers.
October is Operation Bushmaster season for Uniformed Services University (USU) medical and nursing students.
Federal medicine played a crucial role in the development of a new online tool to better predict which middle-aged adults are at the greatest risk of having acute myocardial infarction or stroke over the next decade.
Short-term intensive outpatient treatment is more effective for post-traumatic stress disorder in military veterans than longer-term therapy, a new study suggested.
Rates of suicide among younger veterans (ages 18-34) “increased substantially in recent years,” climbing from 40.4 suicide deaths per 100,000 population in 2015 to 45 suicide deaths per 100,000 population in 2016, according to a new report.
More than half of 15 VAMCs classified as “high risk” in the October 2017 Strategic Analytics for Improvement and Learning report moved out of that category in the most recent update. But one, the DCVAMC in Washington declined and is now considered “critical.”
© 2000-2018. All Materials Copyright Marathon Medical Communications, Inc.